Emedastine
Back to searchMolecule Structure
Scientific Name
Emedastine
Description of the Drug
Emedastine is a selective H1-receptor antagonist used topically to manage symptoms of allergic conjunctivitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01084
http://www.drugbank.ca/drugs/DB01084
Brand Name(s)
Not Available
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL29770 | ||
| PharmGKB | PA164751802 | ||
| Human Metabolome Database | HMDB0015216 | ||
| DrugBank | DB01084 | ||
| PubChem: Thomson Pharma | 14873901 | ||
| PubChem | 3219 | ||
| LINCS | LSM-5331 | ||
| Nikkaji | J253.163A | ||
| BindingDB | 50019624 | ||
| EPA CompTox Dashboard | DTXSID7048243 | ||
| DrugCentral | 999 | ||
| ChemicalBook | CB8728076 | ||
| Guide to Pharmacology | 7174 | ||
| rxnorm | EMEDASTINE | EMADINE | EMEDASTINE DIFUMARATE |
| KEGG Ligand | C07785 | ||
| ChEBI | 4779 | ||
| ZINC | ZINC000001530912 |
